11/20/2008
Despite previous beliefs that Heparin contaminated with over sulfated chondroitin sulfate was in circulation in the United States beginning in the Fall of 2007, new information confirms that several manufacturers received contaminated heparin API (active pharmaceutical ingredient) from Scientific Protein Laboratories, L.L.C. as early as December 2006.
This means that contaminated finished heparin could have been ingested by patients in the U.S. earlier than Fall of 2007. Companies who received contaminated Heparin API before Fall of 2007 include B. Braun, Covidien, Becton Dickinson, Beckman, Emisphere, and Medefil.
This information about the heparin catastrophe is provided by Attorney Gordon Johnson, in conjunction with the Nolan Law Group of Chicago, IL. The Johnson Law Office is affiliated with The Nolan Law Group on Heparin litigation. The Nolan Law Group is presently involved in the litigation on behalf of those affected by the distribution of contaminated heparin.
Thursday, November 20, 2008
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment